These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28929818)

  • 21. Multicriteria decision analysis and core values for enhancing vaccine-related decision-making.
    Barocchi MA; Black S; Rappuoli R
    Sci Transl Med; 2016 Jun; 8(345):345ps14. PubMed ID: 27358496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stakeholder Participation for Legitimate Priority Setting: A Checklist.
    Jansen MPM; Baltussen R; Bærøe K
    Int J Health Policy Manag; 2018 Nov; 7(11):973-976. PubMed ID: 30624870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-criteria decision approach for ranking unmet needs in healthcare.
    Cleemput I; Devriese S; Kohn L; Westhovens R
    Health Policy; 2018 Aug; 122(8):878-884. PubMed ID: 29983193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion.
    Diaby V; Goeree R; Hoch J; Siebert U
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):13-9. PubMed ID: 25267699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
    Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
    Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-based decision making for vaccines: the need for an ethical foundation.
    Field RI; Caplan AL
    Vaccine; 2012 Feb; 30(6):1009-13. PubMed ID: 22197581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
    Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conceptual frameworks and key dimensions to support coverage decisions for vaccines.
    González-Lorenzo M; Piatti A; Coppola L; Gramegna M; Demicheli V; Melegaro A; Tirani M; Parmelli E; Auxilia F; Moja L;
    Vaccine; 2015 Feb; 33(9):1206-17. PubMed ID: 25533328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
    Mühlbacher AC; Kaczynski A
    Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.
    Angelis A; Kanavos P
    Pharmacoeconomics; 2016 May; 34(5):435-46. PubMed ID: 26739955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.
    Phelps C; Madhavan G; Rappuoli R; Levin S; Shortliffe E; Colwell R
    Milbank Q; 2016 Mar; 94(1):109-25. PubMed ID: 26994711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priority setting and cardiac surgery: a qualitative case study.
    Walton NA; Martin DK; Peter EH; Pringle DM; Singer PA
    Health Policy; 2007 Mar; 80(3):444-58. PubMed ID: 16757057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Communicating vaccine safety during the development and introduction of vaccines.
    Kochhar S
    Curr Drug Saf; 2015; 10(1):55-9. PubMed ID: 25859676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
    Yazdani S; Jadidfard MP
    Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the full public health value of vaccination.
    Gessner BD; Kaslow D; Louis J; Neuzil K; O'Brien KL; Picot V; Pang T; Parashar UD; Saadatian-Elahi M; Nelson CB
    Vaccine; 2017 Nov; 35(46):6255-6263. PubMed ID: 28986035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
    Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
    Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of information for managing contaminated sediments.
    Bates ME; Sparrevik M; de Lichy N; Linkov I
    Environ Sci Technol; 2014 Aug; 48(16):9478-85. PubMed ID: 24957130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016.
    Drake JI; de Hart JCT; Monleón C; Toro W; Valentim J
    J Mark Access Health Policy; 2017; 5(1):1360545. PubMed ID: 29081919
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.
    Schlander M
    J Med Ethics; 2008 Jul; 34(7):534-9. PubMed ID: 18591289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.